Every new development in aging science, biohacking and new therapies, found as it happens, read at the original source and labeled by how strong the evidence is. We don’t tell you what works. We show you what was found.
In a six-month study of 536 men, a slow-release pill version of minoxidil, the active ingredient in Rogaine, grew more hair than a dummy pill. The results come from the company and have not been independently checked yet.
In a six-month study of 536 men, a slow-release pill version of minoxidil, the active ingredient in Rogaine, grew more hair than a dummy pill. The results come from the company and have not been independently checked yet.
In a year-long study of 410 people with early Parkinson’s, the supplement nicotinamide riboside (NR) raised a molecule cells use for energy, but did not slow the disease. Symptoms got slightly worse than on a dummy pill.
Charalampos Tzoulis7 sources · 5 minNovo Nordisk and Eli Lilly told an aging conference that people taking semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) appeared to age more slowly on lab estimates of biological age. Nothing has been peer reviewed yet.
Three people with glaucoma had no serious side effects in the eight weeks after a single eye injection, and two showed some improvement in their field of vision, Life Biosciences said. It is a very early, company-reported result.
Roche's PrevenTRON study will give an experimental antibody or a placebo (a dummy treatment) to about 1,600 people aged 55 to 80 who have no memory problems but carry a blood marker linked to Alzheimer's.
In 42 people with a scarring lung disease, six separate blood-protein aging tests all read younger on an experimental AI-designed drug. The split dose gave the steadiest signal, and the result is not proof it slows aging.
Alex Zhavoronkov10 sources · 6 minuniQure has asked US and UK regulators to approve its one-time Huntington's gene therapy. The request rests on small early trials compared with untreated patients from outside the studies.
Try a shorter search or another topic.
The biology of aging and the research trying to slow or reverse it: cell rejuvenation, worn-out "zombie" cells, aging clocks and lifespan studies.
Big new trials of longevity and age-related treatments: what started, what finished and what the numbers say.
Memory, Alzheimer's, Parkinson's and keeping the brain sharp with age.
Treatments that fix or add genes, or use living cells as medicine.
New hair-loss treatments from lab to clinic, with how strong the evidence is for each.
Popular longevity supplements and compounds, read for what was actually measured and in whom.
How AI is being used to find drugs, design treatments and measure aging.
First-of-their-kind results that change the outlook for a disease.
Watching for newsHeart disease, blood pressure, cholesterol and the treatments that protect the heart and blood vessels.
Watching for newsOzempic-style drugs, diabetes, blood sugar and how weight and metabolism shape aging.
Watching for newsNew ways to catch cancer early, treat it and prevent it, and how cancer risk changes with age.
Watching for newsRegrowing and repairing tissue: stem cells, organ repair and regenerative medicine.
Watching for newsSkin aging, wrinkles, sun damage and what the evidence says about treatments that claim to help.
Watching for newsVision and hearing loss with age, and the treatments trying to save or restore them.
Watching for newsOsteoporosis, arthritis and muscle loss with age, and what keeps people strong and mobile.
Watching for newsWhat studies say about training, strength, endurance and movement for a longer, healthier life.
Watching for newsSleep and aging: research on how much, how well, and what improves it.
Watching for newsDiets, fasting, calorie restriction and what eating patterns do to health and aging.
Watching for newsMenopause, testosterone and other hormones, and how they affect aging in women and men.
Watching for newsReproductive aging, egg and sperm health, and new fertility science.
Watching for newsThe aging immune system, chronic inflammation, vaccines and infections in later life.
Watching for newsMental health, stress, loneliness and psychedelic medicine in the longevity world.
Watching for newsWhat the best-known self-experimenters are doing, measuring and claiming, separated from what has been tested.
Watching for newsBiological age tests, blood panels, scans and wearables: what they measure and how much to trust them.
Watching for newsDrugs and research aimed at helping dogs and cats live longer, healthier lives.
Watching for newsThe companies, money and deals behind the longevity industry.
Watching for newsFDA and other regulators, laws and policy shaping longevity medicine.
Watching for newsWe scan journals, preprints, trial registries, regulators, company news and the people in the field every 6 hours.
Every story goes back to the paper, the registry record or the person’s own words, cross-checked with independent reporting.
A mouse study, a company claim and a randomized trial are not the same thing. Each story says which one it is.
We don’t tell you what works. We report what was measured, in whom, and what is still unknown.
David Sinclair
